Sanofi Expands Global Capacity Centre in Hyderabad with Major Investment

Sanofi Healthcare India Pvt. has announced a significant expansion of its global capacity centre (GCC) in Hyderabad. With plans to invest €400 million over the next six years, including €100 million by next year, this initiative underscores Sanofi’s long-term strategy to establish a deep footprint in the region.

Major Investment and Expansion Plans

Madeleine Roach, executive vice-president of business operations at Sanofi, stated in a press conference that the Hyderabad GCC will grow to host approximately 2,600 employees over the next two years, making it the largest of Sanofi’s four global hubs. Currently, the centre employs 1,000 people.

“We make quite a significant commitment. This is obviously a long-term strategy. To set our deep footprint here, we are going to make a commitment of €400 million until 2030 (about Rs 3,600 crore),” Roach said. The investments will primarily focus on acquiring talent, building new capabilities, and developing state-of-the-art facilities in Hyderabad.”

Embracing AI and Enhancing Capabilities

Established in 2019, the Hyderabad hub has grown from a medical hub to providing several best-in-class services for Sanofi’s global functions and affiliates. Emmanuel Frenehard, executive vice-president and chief digital officer of Sanofi, emphasized the company’s ambition to be the first biopharma company powered by Artificial Intelligence (AI) at scale.

“From discovery to treatment, we are using AI ethically and safely to get to market faster with our drugs as there’s plenty of unmet needs. We intend to onboard talent at the Hyderabad hub to embrace the power of AI across our value chain to harness the pace of scientific discovery, improve our productivity, and place better decision intelligence in the hands of our people,” Frenehard said.

Conclusion: The expansion of Sanofi’s global capacity centre in Hyderabad marks a significant step in the company’s commitment to innovation and growth. With a substantial investment and a focus on AI and talent acquisition, Sanofi aims to enhance its global operations and address unmet needs in the biopharma industry. The facility was inaugurated at HiTECH City by Telangana minister for industries D Sridhar Babu, alongside Arunis Chawla, secretary of the department of pharmaceuticals, and Thierry Berthelot, consul general of France in Bangalore.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.